These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 10235781

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Management of hyperlipidemias.
    Murphy BF.
    JAMA; ; 230(12):1683-91. PubMed ID: 4373590
    [No Abstract] [Full Text] [Related]

  • 8. Effect of a new niacin derivative (nicotinic hexaester of D-glucitol) on type IIA, IIB and IV hyperlipoproteinemia in man.
    Avogaro P, Bittolo-Bon G, Pais M, Taroni GC.
    Pharmacol Res Commun; 1977 Jun; 9(6):599-606. PubMed ID: 197548
    [No Abstract] [Full Text] [Related]

  • 9. Neonatal diagnosis of Fredrickson type II hyperlipoproteinaemia.
    Andersen GE.
    Postgrad Med J; 1975 Jun; 51(8):suppl 93-4. PubMed ID: 215988
    [Abstract] [Full Text] [Related]

  • 10. [Therapy of primary hyperlipoproteinemia types IIa, IIb and IV using beta pyridylcarbinol Study on three phases under ambulatory conditions].
    Klemens UH, von Löwis P.
    Dtsch Med Wochenschr; 1973 Jun 15; 98(24):1197-202. PubMed ID: 4350685
    [No Abstract] [Full Text] [Related]

  • 11. [Clofibrate action on the lipoprotein composition in primary type IV and type V hyperlipoproteinemia].
    Weisweiler P, Schwandt P.
    Verh Dtsch Ges Inn Med; 1973 Jun 15; 83():398-401. PubMed ID: 206058
    [No Abstract] [Full Text] [Related]

  • 12. [Diet therapy in hyperlipoproteinemias].
    Canzler H.
    Z Allgemeinmed; 1974 Jan 20; 50(2):53-61. PubMed ID: 4361378
    [No Abstract] [Full Text] [Related]

  • 13. [Therapy of hyperlipoproteinemia type II with Xantinol-nicotinate (author's transl)].
    Haacke H, Parwaresch MR, Mäder C.
    Med Klin; 1977 Jul 08; 72(27):1183-7. PubMed ID: 196168
    [Abstract] [Full Text] [Related]

  • 14. [Laboratory study of dyslipidemias and dyslipoproteinemias].
    Mihalache N, Georgescu M.
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1974 Jul 08; 26(8):905-13. PubMed ID: 4157095
    [No Abstract] [Full Text] [Related]

  • 15. Should hyperlipoproteinemia be treated in patients with coronary artery disease?
    Rider AK.
    JAMA; 1975 Jul 21; 233(3):275-7. PubMed ID: 168412
    [No Abstract] [Full Text] [Related]

  • 16. The dyslipoproteinemias.
    Brown DF.
    Acta Diabetol Lat; 1972 Dec 21; 9 Suppl 2():18-52. PubMed ID: 4369284
    [No Abstract] [Full Text] [Related]

  • 17. Pseudohomozygous type II hyperlipoproteinemia.
    Morganroth J, Levy RI, McMahon AE, Gotto AM.
    J Pediatr; 1974 Nov 21; 85(5):639-43. PubMed ID: 4370845
    [No Abstract] [Full Text] [Related]

  • 18. [Beta-sitosterin in unsuccessfully pretreated patients with hypercholesteremia. Simultaneously, a contribution to dose dependence].
    Mühlfellner G, Mühlfellner O, Kaffarnik H.
    Med Klin; 1976 Apr 30; 71(18):775-8. PubMed ID: 178987
    [Abstract] [Full Text] [Related]

  • 19. [The quantitative evaluation of lipid spectrum in population studies (author's transl)].
    Ricci G, Urbinati GC, Menotti A, Angelico R.
    G Ital Cardiol; 1974 Apr 30; 4(3):341-9. PubMed ID: 4367440
    [No Abstract] [Full Text] [Related]

  • 20. Clinical evaluation of cinnarizine in hyperlipaemic patients.
    Saba P, Galeone F, Salvadorini F, Guarguaglini M, Houben JL.
    G Clin Med; 1974 Aug 30; 55(8):586-99. PubMed ID: 4377134
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.